Eli Lilly and (LLY) Revenue — Quarter Ended Sep 30, 2023
Eli Lilly reported a substantial increase in revenue for the third quarter. The growth was seen both sequentially from the previous quarter and compared to the same period last year.
Key takeaway
Quarter ended Sep 30, 2023 · FY2023 Q3
Eli Lilly reported a substantial increase in revenue for the third quarter. The growth was seen both sequentially from the previous quarter and compared to the same period last year.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$9.5B
Revenue reported for this quarter.
Quarter-over-quarter
+14.3%
Change from the immediately preceding quarter.
Year-over-year
+36.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$32.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $7.3B | -8.7% |
| Mar 31, 2023 | $7B | -10.9% |
| Jun 30, 2023 | $8.3B | +28.1% |
| Sep 30, 2023 | $9.5B | +36.8% |
Revenue performance
The revenue growth rate accelerated compared to the immediate prior quarter, building on a strong upward trend throughout the year.
Quarterly comparison
Revenue rose from the preceding quarter and posted a significant gain from the same quarter a year earlier.
What to watch
The company's ability to sustain its robust year-over-year revenue growth will be a key focus in coming quarters.